As of today, the Company has a new and improved re
Post# of 148112
(Total Views: 507)
Posted On: 09/09/2024 8:42:25 AM
As of today, the Company has a new and improved relationship with the FDA – one that will remain a critical priority for the management team in the coming years. We believe the Company has sufficient cash on hand to commence the contemplated clinical trials and push our development initiatives forward into 2025.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼